Publication | Open Access
T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2
65
Citations
24
References
2014
Year
Ovarian CarcinosarcomasNovel Antibody-drug ConjugateMedicineGynecologyImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyEndocrine-related CancerOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1